Jing‐Song Ou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jing‐Song Ou has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Bassam T. Wakim
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, USA
1 shared publication- Brian D. Halligan
Division of Gastroenterology and Hepatology, University of Michigan Health System, Ann Arbor, USA
1 shared publication Danielle B. Peterson
Department of Surgery, Medical College of Wisconsin and Children's Research Institute, Milwaukee, WI 53226, USA
1 shared publication- Keith T. Oldham
Children’s Hospital of Wisconsin, Children’s Corporate Center
1 shared publication Kirkwood A. Pritchard
Department of Surgery, Medical College of Wisconsin and Children’s Research Institute, Milwaukee, WI, USA
1 shared publication- Simon N. Twigger
Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
1 shared publication
Latest Publications
- 18 June 2008
- Published by Wiley in Proteomics
- Vol. 8 (12) , 2430-2446
Comparative proteomic analysis of PAI‐1 and TNF‐alpha‐derived endothelial microparticles
Endothelium‐derived microparticles (EMPs) are small vesicles released from endothelial cells in response to cell injury, apoptosis, or activation. Elevated concentrations of EMPs have been associated with many inflammatory and vascular diseases. EMPs also mediate long range signaling and alter downstream cell function. Unfortunately, the molecular and cellular basis of microparticle production and downstream cell function is poorly understood. We hypothesize that EMPs generated by different agonists will produce distinct populations of EMPs with unique protein compositions. To test this hypothesis, different EMP populations were generated from human umbilical vein endothelial cells by stimulation with plasminogen activator inhibitor type 1 (PAI‐1) or tumor necrosis factor‐alpha (TNF‐α) and subjected to proteomic analysis by LC/MS. We identified 432 common proteins in all EMP populations studied. Also identified were 231 proteins unique to control EMPs, 104 proteins unique to PAI‐1 EMPs and 70 proteins unique to TNF‐α EMPs. Interestingly, variations in protein abundance were found among many of the common EMP proteins, suggesting that differences exist between EMPs on a relative scale. Finally, gene ontology (GO) and KEGG pathway analysis revealed many functional similarities and few differences between the EMP populations studied. In summary, our results clearly indicate that EMPs generated by PAI‐1 and TNF‐α produce EMPs with overlapping but distinct protein compositions. These observations provide fundamental insight into the mechanisms regulating the production of these particles and their physiological role in numerous diseases.
- 18 June 2008
- Published by Wiley in Proteomics
- Vol. 8 (12) , 2430-2446
Comparative proteomic analysis of PAI‐1 and TNF‐alpha‐derived endothelial microparticles
Endothelium‐derived microparticles (EMPs) are small vesicles released from endothelial cells in response to cell injury, apoptosis, or activation. Elevated concentrations of EMPs have been associated with many inflammatory and vascular diseases. EMPs also mediate long range signaling and alter downstream cell function. Unfortunately, the molecular and cellular basis of microparticle production and downstream cell function is poorly understood. We hypothesize that EMPs generated by different agonists will produce distinct populations of EMPs with unique protein compositions. To test this hypothesis, different EMP populations were generated from human umbilical vein endothelial cells by stimulation with plasminogen activator inhibitor type 1 (PAI‐1) or tumor necrosis factor‐alpha (TNF‐α) and subjected to proteomic analysis by LC/MS. We identified 432 common proteins in all EMP populations studied. Also identified were 231 proteins unique to control EMPs, 104 proteins unique to PAI‐1 EMPs and 70 proteins unique to TNF‐α EMPs. Interestingly, variations in protein abundance were found among many of the common EMP proteins, suggesting that differences exist between EMPs on a relative scale. Finally, gene ontology (GO) and KEGG pathway analysis revealed many functional similarities and few differences between the EMP populations studied. In summary, our results clearly indicate that EMPs generated by PAI‐1 and TNF‐α produce EMPs with overlapping but distinct protein compositions. These observations provide fundamental insight into the mechanisms regulating the production of these particles and their physiological role in numerous diseases.